Possible Alterations in β-Synuclein, the Non-Amyloidogenic Homologue of α-Synuclein, during Progression of Sporadic α-Synucleinopathies
α-Synucleinopathies are neurodegenerative disorders that are characterized by progressive decline of motor and non-motor dysfunctions. α-Synuclein (αS) has been shown to play a causative role in neurodegeneration, but the pathogenic mechanisms are still unclear. Thus, there are no radical therapies...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2012-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/13/9/11584 |
id |
doaj-dcc940451c274b048c16b0091891e5b9 |
---|---|
record_format |
Article |
spelling |
doaj-dcc940451c274b048c16b0091891e5b92020-11-24T21:44:28ZengMDPI AGInternational Journal of Molecular Sciences1422-00672012-09-01139115841159210.3390/ijms130911584Possible Alterations in β-Synuclein, the Non-Amyloidogenic Homologue of α-Synuclein, during Progression of Sporadic α-SynucleinopathiesMakoto HashimotoKazunari SekiyamaAkio SekigawaMasayo FujitaYoshiki Takamatsuα-Synucleinopathies are neurodegenerative disorders that are characterized by progressive decline of motor and non-motor dysfunctions. α-Synuclein (αS) has been shown to play a causative role in neurodegeneration, but the pathogenic mechanisms are still unclear. Thus, there are no radical therapies that can halt or reverse the disease’s progression. β-Synuclein (βS), the non-amyloidogenic homologue of αS, ameliorates the neurodegeneration phenotype of αS in transgenic (tg) mouse models, as well as in cell free and cell culture systems, which suggests that βS might be a negative regulator of neurodegeneration caused by αS, and that “loss of function” of βS might be involved in progression of α-synucleinopathies. Alternatively, it is possible that “toxic gain of function” of wild type βS occurs during the pathogenesis of sporadic α-synucleinopathies, since tg mice expressing dementia with Lewy bodies-linked P123H βS develop progressive neurodegeneration phenotypes, such as axonal pathology and dementia. In this short review, we emphasize the aspects of “toxic gain of function” of wild type βS during the pathogenesis of sporadic α-synucleinopathies.http://www.mdpi.com/1422-0067/13/9/11584α-synucleinopathiesα-synucleinβ-synucleindementia with Lewy bodiestoxic gain of function |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Makoto Hashimoto Kazunari Sekiyama Akio Sekigawa Masayo Fujita Yoshiki Takamatsu |
spellingShingle |
Makoto Hashimoto Kazunari Sekiyama Akio Sekigawa Masayo Fujita Yoshiki Takamatsu Possible Alterations in β-Synuclein, the Non-Amyloidogenic Homologue of α-Synuclein, during Progression of Sporadic α-Synucleinopathies International Journal of Molecular Sciences α-synucleinopathies α-synuclein β-synuclein dementia with Lewy bodies toxic gain of function |
author_facet |
Makoto Hashimoto Kazunari Sekiyama Akio Sekigawa Masayo Fujita Yoshiki Takamatsu |
author_sort |
Makoto Hashimoto |
title |
Possible Alterations in β-Synuclein, the Non-Amyloidogenic Homologue of α-Synuclein, during Progression of Sporadic α-Synucleinopathies |
title_short |
Possible Alterations in β-Synuclein, the Non-Amyloidogenic Homologue of α-Synuclein, during Progression of Sporadic α-Synucleinopathies |
title_full |
Possible Alterations in β-Synuclein, the Non-Amyloidogenic Homologue of α-Synuclein, during Progression of Sporadic α-Synucleinopathies |
title_fullStr |
Possible Alterations in β-Synuclein, the Non-Amyloidogenic Homologue of α-Synuclein, during Progression of Sporadic α-Synucleinopathies |
title_full_unstemmed |
Possible Alterations in β-Synuclein, the Non-Amyloidogenic Homologue of α-Synuclein, during Progression of Sporadic α-Synucleinopathies |
title_sort |
possible alterations in β-synuclein, the non-amyloidogenic homologue of α-synuclein, during progression of sporadic α-synucleinopathies |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1422-0067 |
publishDate |
2012-09-01 |
description |
α-Synucleinopathies are neurodegenerative disorders that are characterized by progressive decline of motor and non-motor dysfunctions. α-Synuclein (αS) has been shown to play a causative role in neurodegeneration, but the pathogenic mechanisms are still unclear. Thus, there are no radical therapies that can halt or reverse the disease’s progression. β-Synuclein (βS), the non-amyloidogenic homologue of αS, ameliorates the neurodegeneration phenotype of αS in transgenic (tg) mouse models, as well as in cell free and cell culture systems, which suggests that βS might be a negative regulator of neurodegeneration caused by αS, and that “loss of function” of βS might be involved in progression of α-synucleinopathies. Alternatively, it is possible that “toxic gain of function” of wild type βS occurs during the pathogenesis of sporadic α-synucleinopathies, since tg mice expressing dementia with Lewy bodies-linked P123H βS develop progressive neurodegeneration phenotypes, such as axonal pathology and dementia. In this short review, we emphasize the aspects of “toxic gain of function” of wild type βS during the pathogenesis of sporadic α-synucleinopathies. |
topic |
α-synucleinopathies α-synuclein β-synuclein dementia with Lewy bodies toxic gain of function |
url |
http://www.mdpi.com/1422-0067/13/9/11584 |
work_keys_str_mv |
AT makotohashimoto possiblealterationsinbsynucleinthenonamyloidogenichomologueofasynucleinduringprogressionofsporadicasynucleinopathies AT kazunarisekiyama possiblealterationsinbsynucleinthenonamyloidogenichomologueofasynucleinduringprogressionofsporadicasynucleinopathies AT akiosekigawa possiblealterationsinbsynucleinthenonamyloidogenichomologueofasynucleinduringprogressionofsporadicasynucleinopathies AT masayofujita possiblealterationsinbsynucleinthenonamyloidogenichomologueofasynucleinduringprogressionofsporadicasynucleinopathies AT yoshikitakamatsu possiblealterationsinbsynucleinthenonamyloidogenichomologueofasynucleinduringprogressionofsporadicasynucleinopathies |
_version_ |
1725909973005762560 |